Mitoxantrone hydrochloride
CAS No. 70476-82-3
Mitoxantrone hydrochloride( NCI 301739; Novantrone; NSC 301739 )
Catalog No. M15709 CAS No. 70476-82-3
Mitoxantrone Dihydrochloride, a type II topoisomerase inhibitor, is an anthracenedione-derived antineoplastic agent.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100mg | 65 | In stock |
|
50mg | 40 | In stock |
|
25mg | 27 | In stock |
|
Biological Information
-
Product NameMitoxantrone hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionMitoxantrone Dihydrochloride, a type II topoisomerase inhibitor, is an anthracenedione-derived antineoplastic agent.
-
DescriptionMitoxantrone Dihydrochloride, a type II topoisomerase inhibitor, is an anthracenedione-derived antineoplastic agent.
-
SynonymsNCI 301739; Novantrone; NSC 301739
-
PathwayCell Cycle/DNA Damage
-
TargetTopoisomerase
-
RecptorTopo II
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number70476-82-3
-
Formula Weight517.40
-
Molecular FormulaC22H30Cl2N4O6
-
Purity>98%(HPLC)
-
SolubilityWater: 89 mg/mL (172.01 mM); DMSO: 89 mg/mL (172.01 mM)
-
SMILESCl.Cl.OCCNCCNC1=C2C(=O)C3=C(O)C=CC(O)=C3C(=O)C2=C(NCCNCCO)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Seitz M. Curr Opin Rheumatol, 1999, 11(3), 226-232.
molnova catalog
related products
-
10-Hydroxycamptothec...
(S)-10-Hydroxycamptothecin is a clinical therapy agent against hepatoma.
-
Irinotecan Hydrochlo...
Irinotecan Hcl(CPT-11 Hcl) prevents DNA from unwinding by inhibition of topoisomerase 1.
-
Pirarubicin
Pirarubicin is an anthracycline antibiotic, and also a DNA/RNA synthesis inhibitor by intercalating into Dna and interacts with topoisomerase II, used as an antineoplastic agent.